ProfileGDS2971 / 11.1.19.1
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 84% 4% 94% 93% 6% 76% 64% 58% 43% 80% 82% 92% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)0.79192784
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-1.447964
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 21.1634894
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)1.3138893
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)-1.216866
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.38145776
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.23865864
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)0.11376958
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)-0.044252643
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)0.73740780
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.70309682
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)1.7154892